2025 · 2nd Quarter (Apr 1 - June 30)

ZIMMER BIOMET, INC.

Filed by ZIMMER BIOMET, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 15, 2025
Income: Not reported
Expenses: $190,000.00
Registrant: ZIMMER BIOMET, INC.
Client: ZIMMER BIOMET, INC.
Filing UUID: 707dc929-4b2b-491f-a4a3-531705326d3a
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment

TRD · Trade (domestic/foreign)

Trade Issues/Policy

TAX · Taxation/Internal Revenue Code

Tax Issues

ENV · Environment/Superfund

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

SCI · Science/Technology

Medical Device Electronic Labeling Act (H.R. 1539)

Literal federal measure citations: H.R. 1539

HCR · Health Issues

Assorted issues related to the FDA

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.